JBF Capital »

Monte Rosa Therapeutics shares owned by JBF Capital

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by JBF Capital from 13F filings

Historical chart of JBF Capital investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by JBF Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by JBF Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 149k 7.41

More positions owned by JBF Capital

Vanguard S&p 500 Etf Etf (VOO)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Green Brick Partners (GRBK)
Invesco Qqq Trust Etf, Series 1 Etf Etf (QQQ)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Wells Fargo & Company (WFC)
Lowe's Companies (LOW)
Netflix (NFLX)
NVIDIA Corporation (NVDA)
United Rentals (URI)
Broadcom (AVGO)
Dell Technologies (DELL)
Crowdstrike Hldgs Inc cl a (CRWD)

View all positions for JBF Capital

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Versant Venture Management
Baker Bros. Advisors
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
Aisling Capital Management
Alphabet
Geode Capital Management
Marshall Wace
State Street Corporation
Vestal Point Capital
Northern Trust

View all funds holding Monte Rosa Therapeutics